Search research articles
Contact Us
Filters
Showing results (1-10 of 308) with videos related to
Page
of 31
Sort By:
Current Rheumatology Reports
|
January 8, 2013
Morphogen pathways in systemic sclerosis
Christian Beyer, Jörg H W Distler
Experimental Dermatology
|
October 15, 2013
Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?
Clara Dees, Jörg H W Distler
Deutsche Medizinische Wochenschrift (1946)
|
April 1, 2015
[Systemic sclerosis - an update]
Christina Bergmann, Jörg H W Distler
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Reply
Alina Soare, Jörg H W Distler
Therapeutic Advances in Musculoskeletal Disease
|
August 15, 2022
A broad look into the future of systemic sclerosis
Gabriela Riemekasten, Jörg H W Distler
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 14, 2024
Reply
Jörg H W Distler, Jonas Hallén
Arthritis and Rheumatism
|
September 14, 2012
Changing paradigms in spondylarthritis: the myofibroblast signature
Christian Beyer, Jörg H W Distler
Nature Reviews. Rheumatology
|
July 3, 2010
Inflammation: Microparticles and their roles in inflammatory arthritides
Jörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases
|
May 22, 2007
Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?
Jörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases
|
November 30, 2021
Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis
Jörg H W Distler, Steven O'Reilly
Page
of 31
Search research articles
Search
Showing results (1-10 of 308) with videos related to
Sort By:
Page
of 31
Current Rheumatology Reports
|
January 8, 2013
Morphogen pathways in systemic sclerosis
Christian Beyer, Jörg H W Distler
Experimental Dermatology
|
October 15, 2013
Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?
Clara Dees, Jörg H W Distler
Deutsche Medizinische Wochenschrift (1946)
|
April 1, 2015
[Systemic sclerosis - an update]
Christina Bergmann, Jörg H W Distler
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 6, 2020
Reply
Alina Soare, Jörg H W Distler
Therapeutic Advances in Musculoskeletal Disease
|
August 15, 2022
A broad look into the future of systemic sclerosis
Gabriela Riemekasten, Jörg H W Distler
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 14, 2024
Reply
Jörg H W Distler, Jonas Hallén
Arthritis and Rheumatism
|
September 14, 2012
Changing paradigms in spondylarthritis: the myofibroblast signature
Christian Beyer, Jörg H W Distler
Nature Reviews. Rheumatology
|
July 3, 2010
Inflammation: Microparticles and their roles in inflammatory arthritides
Jörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases
|
May 22, 2007
Cardiotoxicity of imatinib mesylate: an extremely rare phenomenon or a major side effect?
Jörg H W Distler, Oliver Distler
Annals of the Rheumatic Diseases
|
November 30, 2021
Epigenetic profiling of twins identify repression of KLF4 as a novel pathomechanism in systemic sclerosis
Jörg H W Distler, Steven O'Reilly
Page
of 31